Different genomic imbalances in low- and high-grade HCV-related lymphomas [13]

Leukemia

Volumn 22, Issue 1, 2008, Pages 219-222

  Matteucci, C ^a   Bracci, M ^b   Barba, G ^a   Carbonari, M ^b   Casato, M ^b   Visentini, M ^b   Pulsoni, A ^b   Varasano, E ^a   Roti, G ^a   Starza, R ^a   Crescenzi, B ^a   Martelli, M F ^a   Fiorilli, M ^b   Mecucci, C ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; GLYCOLIPID; GLYCOPROTEIN; GLYCOSYLTRANSFERASE; GLYCOSYLTRANSFERASE LIKE DOMAIN CONTAINING PROTEIN 1; PROTEIN BCL 6; PROTEIN P63; RIBAVIRIN; UNCLASSIFIED DRUG;

ADULT; AGED; B CELL LYMPHOMA; CARCINOGENESIS; CHROMOSOME 1; CHROMOSOME 2; CHROMOSOME 3; CHROMOSOME 4; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CRYOGLOBULINEMIA; CYTOGENETICS; DOWN REGULATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENE EXPRESSION REGULATION; GENE LOCATION; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; HELICOBACTER PYLORI; HEPATITIS C; HEPATITIS C VIRUS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LETTER; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; MALE; MOLECULAR GENETICS; MONOTHERAPY; NONHODGKIN LYMPHOMA; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; SPLENECTOMY; SPLENOMEGALY;

EID: 38349048236     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2404872     Document Type: Letter

References (8)

1. Ivanovski M, Silvestri F, Pozzato G, Anand S, Mazzaro C, Burrone OR et al. Somatic hypermutation, clonal diversity, and preferential expression of the VH 51p1/VL kv325 immunoglobulin gene combination in hepatitis C virus-associated immunocytomas. Blood 1998; 91: 2433-2442.
2. Suarez F, Lortholary O, Hermine O, Lecuit M. Infection-associated lymphomas derived from marginal zone B-cells: A model of antigen-driven lymphoproliferation. Blood 2006; 107: 3034-3044.
3. Kelaidi C, Rollot F, Park S, Tulliez M, Christoforov B, Calmus Y et al. Response to antiviral treatment in hepatitis C virus-issociated marginal zone lymphomas. Leukemia 2004; 18: 1711-1716.
4. Libra M, De Re V, De Vita S, Gasparotto D, Gloghini A, Rupolo M et al Low frequency of Bcl-2 rearrangement in HCV-associated non-Hodgkin's lymphoma tissue. Leukemia 2003; 17: 1433-1436.
5. Algara P, Mateo MS, Sanchez-Beato M, Mollejo M, Navas IC, Romero L et al. Analysis of the IgV(H) somatic mutations in splenic marginal zone lymphoma defines a group of unmutated cases with frequent 7q deletion and adverse clinical course. Blood 2002; 99: 1299-1304.
6. Tornillo L, Carafa V, Richter J, Sauter G, Moch H, Minola E et al. Marked genetic similarities between hepatitis B virus-positive and hepatitis C virus-positive hepatocellular carcinomas. J Pathol 2000; 192: 307-312.
7. Barth TFE; Bentz M, Leithäuser F, Stilgenbauer S, Siebert R, Schlotter M et al. Molecular-cytogenetic comparison of mucosa-associated marginal zone B-cell lymphoma and large B-cell lymphoma arising in the gastro-intestinal tract. Genes Chromosomes Cancer 2001; 31: 316-325.
8. Chen W, Houldsworth J, Olshen AB, Nanjangud G, Chaganti S, Venkatraman ES et al. Array comparative genomic hybridization reveals genomic copy number changes associated with outcome in diffuse large B-cell lymphomas. Blood 2006; 107: 2477-2485.